APAC Cannabis Franchise pioneer Releaf Group Ltd is excited to announce the successful execution of an agreement with South African Health Products Regulatory Authority (SAHPRA) and the International Narcotics Control Board (INCB) to open a mutually beneficial world-first medicinal cannabis supply chain between the two countries.
Wholly owned subsidiary Releaf Dispensaries Pty Ltd is the first Australian corporation to execute a supply agreement for the importation of premium quality medicinal cannabis products into Australia from South Africa’s leading GMP licensed producer, FarmaGrowers.
“FarmaGrower’ main objective since the beginning was to compete in the international medicinal cannabis space with a specific reference to high THC products. Today, we have turned this vision into a reality by building a fully operational GMP-approved medicinal cannabis facility and signing an international off-take agreement with Releaf Group. We look forward to this new Cultivation and Medical expertise partnership as it aligns with our slogan ‘Growing Health’.” – FarmaGrowers CEO, Mario Marais, on behalf of the Board of Directors.
“We are excited about the opportunity with FarmaGrowers to establish a long-term importation supply chain from a GMP-certified facility in South Africa that will introduce a significant product mix of South African cultivars to the Australia & New Zealand marketplace.” – Releaf Group Ltd CEO, Gary Mackenzie.
Releaf’s specialised team is continually focused on expanding their range of cannabis dried flower to provide a greater variety of therapeutic options, foster positive patient outcomes and to support the roll-out of their Clinic and Dispensary (Pharmacy) Franchise Model. This agreement furthers the company’s strategic endeavours and strengthens their value proposition by enabling doctors and patients to draw from a diverse range of imported and locally produced terpene-rich therapeutic cannabis cultivars.
Both parties would like to thank NICE Partners (UK) for establishing this partnership.